QA: Celgene CORP DE in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000816284_2018_Celgene_CORP_DE.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000816284, Celgene CORP DE

  xvar xval
0 AssetsCurrent 14,892,000,000
1 IntangibleAssetsNetIncludingGoodwill 13,302,000,000
2 PropertyPlantAndEquipmentNet 1,070,000,000
3 remainder_Assets 877,000,000
4 LiabilitiesCurrent 2,987,000,000
5 LiabilitiesNoncurrent 16,382,000,000
6 remainder_Liabilities 3,851,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,075,361,318
9 ResearchAndDevelopmentExpense 7,509,234,042
10 remainder_Expenses 450,295,807
11 remainder_Revenues 14,242,655,704
12 remainder_NetIncome -293,338,350
13 remainder_ComprehensiveNetIncome -157,359,929
  yvar yval
0 Assets 30,141,000,000
1 Liabilities 23,220,000,000
2 Expenses 11,034,891,167
3 Revenues 14,242,655,704
4 StockholdersEquity 6,921,000,000
5 NetIncome 2,914,426,187
6 ComprehensiveNetIncome 2,835,746,222
7 BaseVar 39,544,622,575
8 EconomicCapitalRatiobeforeLimitedLiability 0.672
9 EconomicCapitalRatio 2.03

Edgar->Model Mapping

Feature Distribution

Change over Time